These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33103598)

  • 1. Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel.
    Kumari N; Dalal V; Kumar P; Rath SN
    J Biomol Struct Dyn; 2022 Apr; 40(6):2395-2406. PubMed ID: 33103598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
    Kumari N; Bhargava A; Rath SN
    Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel.
    Kumari N; Giri PS; Rath SN
    Cancer Drug Resist; 2021; 4(4):996-1007. PubMed ID: 35582374
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
    Sakkaki S; Gangarossa G; Lerat B; Françon D; Forichon L; Chemin J; Valjent E; Lerner-Natoli M; Lory P
    Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
    Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
    Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
    Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
    Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZnT1 induces a crosstalk between T-type and L-type calcium channels through interactions with Raf-1 kinase and the calcium channel β2 subunit.
    Mor M; Beharier O; Cook DI; Campbell CR; Gheber LA; Katz A; Moran A; Etzion Y
    Metallomics; 2023 Jun; 15(6):. PubMed ID: 37193665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
    Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Nguyen SJ; Surles NO; Yao L; Barrow JC; Uebele VN; Renger JJ; Clark J; Hutson PH
    Neuropharmacology; 2012 Mar; 62(3):1413-21. PubMed ID: 21110986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAF
    Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet X; Matías-Guiu X; Martí RM; Macià A
    J Invest Dermatol; 2020 Jun; 140(6):1253-1265. PubMed ID: 31877318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaV3.2 T-type Ca2+ channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia.
    Makarenko VV; Ahmmed GU; Peng YJ; Khan SA; Nanduri J; Kumar GK; Fox AP; Prabhakar NR
    J Neurophysiol; 2016 Jan; 115(1):345-54. PubMed ID: 26561606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
    Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
    Yuan H; Sun B; Gao F; Lan M
    Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.
    Huang Z; Gao Y; Hou D
    Hum Cell; 2020 Jul; 33(3):850-858. PubMed ID: 32452013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
    Guo S; Zhang Y; Wu Z; Zhang L; He D; Li X; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109225. PubMed ID: 31325705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.